2m 2m 2m 2m 2m 2m 2m
TILRAY BRANDS (TLRY)
NASDAQ
$5.13-$0.25 (-4.74%)
Price as of Jun 03, 2026 6:12 PM EDT- $659.0MMarket Cap
- 34.37%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
TILRAY BRANDS (TLRY)
$5.13-$0.25 (-4.74%)
Annual
Quarterly
05/31/2025 | 05/31/2024 | 05/31/2023 | 05/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 821.3M +4.10% | 788.9M +25.80% | 627.1M -0.20% | 628.4M +22.47% | |
Cost of Revenue | 580.7M +2.68% | 565.6M +17.79% | 480.2M -6.14% | 511.6M +31.20% | |
Gross Profit | 240.6M +7.71% | 223.4M +51.98% | 147.0M +25.80% | 116.8M -5.17% | |
Sales and Marketing Expense | 37.0M -11.65% | 41.9M +35.54% | 30.9M +0.010% | 30.9M +76.37% | |
Research and Development Expense | -284,000 -55.28% | -635,000 -6.89% | -682,000 -55.07% | -1.5M +82.89% | |
Depreciation and Amortization Expense | 133.5M +5.18% | 126.9M -2.49% | 130.1M -15.81% | 154.6M +127.90% | |
Total Operating Expenses | 2.5B +533.84% | 398.1M -73.75% | 1.5B +108.55% | 727.2M +184.79% | |
Operating Profit | -2.3B +1,206.31% | -174.7M -87.24% | -1.4B +124.39% | -610.4M +361.83% | |
Interest Income | 11.4M -11.32% | 12.8M -61.15% | 33.0M +181.40% | 11.7M N/A | |
Interest Expense | -30.0M -17.79% | -36.4M +168.15% | -13.6M -51.38% | -27.9M -0.12% | |
Interest Income and Expense and Net | -18.6M -21.31% | -23.6M -221.42% | 19.4M +219.93% | -16.2M -42.07% | |
Total Nonoperating Income and Expense | 10.3M +127.18% | -37.8M -43.44% | -66.9M -133.85% | 197.7M +206.94% | |
Income before Taxes | -2.3B +824.57% | -249.0M -82.83% | -1.5B +229.08% | -440.7M +27.74% | |
Income Taxes | -121.0M +354.68% | -26.6M +270.64% | -7.2M +9.77% | -6.5M -27.08% | |
Extraordinary Items | 2.1B N/A | 0 -100.00% | 934.0M +146.93% | 378.2M +646.35% | |
Net Income | -2.2B +792.62% | -245.0M -83.14% | -1.5B +204.67% | -476.8M +29.77% | |
Net Income from Continuing Operations Applicable to Common | -2.3B +824.57% | -249.0M -82.83% | -1.5B +229.08% | -440.7M +27.74% | |
Basic EPS and Net Income | -2.46 +645.45% | -0.33 -85.96% | -2.35 +161.11% | -0.90 -28.00% | |
Diluted EPS and Net Income | -2.46 +645.45% | -0.33 -85.96% | -2.35 +161.11% | -0.90 -28.00% | |
Basic Weighted Average Shares | 890.3M +19.89% | 742.6M +20.17% | 618.0M +28.42% | 481.2M +78.53% | |
Diluted Weighted Average Shares | 890.3M +19.89% | 742.6M +20.17% | 618.0M +28.42% | 481.2M +78.53% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 221.7M -2.92% | 228.3M +10.51% | 206.6M -50.32% | 415.9M -14.85% | |
Short-Term Investments | 34.7M +7.81% | 32.2M -86.70% | 241.9M N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 256.4M -1.60% | 260.5M -41.92% | 448.5M +7.84% | 415.9M -14.85% | |
Total Current Assets | 688.6M +1.61% | 677.7M -12.33% | 773.0M -3.79% | 803.5M -9.07% | |
Accumulated Depreciation | 236.3M +24.64% | 189.6M +29.12% | 146.8M -12.21% | 167.2M +117.55% | |
Property and Plant and Equipment and Net | 568.4M +1.82% | 558.2M +29.93% | 429.7M -26.87% | 587.5M -9.71% | |
Total Long-Term Assets | 11.1M +105.45% | 5.4M +2,330.18% | 222,000 -29.30% | 314,000 -96.21% | |
Total Assets | 2.1B -50.86% | 4.2B -1.99% | 4.3B -20.96% | 5.4B -9.55% | |
Income Taxes Payable | 3.7M -97.14% | 130.9M -21.81% | 167.4M -14.89% | 196.6M -26.03% | |
Total Short-Term Debt | 21.9M -35.20% | 33.9M -84.73% | 221.8M +158.11% | 85.9M +89.56% | |
Total Current Liabilities | 280.3M -6.31% | 299.2M -30.90% | 433.0M +54.45% | 280.3M -30.13% | |
Total Long-Term Debt | 234.9M -18.41% | 287.9M -19.56% | 357.9M +203.64% | 117.9M -29.62% | |
Total Long-Term Liabilities | 855,000 +850.00% | 90,000 -58.14% | 215,000 +12.57% | 191,000 -95.11% | |
Total Liabilities | 584.8M -24.89% | 778.5M -20.34% | 977.3M -3.08% | 1.0B -35.37% | |
Retained Earnings | -4.8B +82.19% | -2.7B +10.14% | -2.4B +150.87% | -962.9M +98.10% | |
Total Stockholders Equity | 1.5B -56.10% | 3.4B +3.84% | 3.3B -24.62% | 4.4B -1.35% | |
Total Shares Outstanding | 1.1B +27.50% | 831.9M +26.69% | 656.7M +23.28% | 532.7M +19.32% | |
Cash Flow | |||||
Cash from Operating Activities | -94.6M +206.10% | -30.9M -490.91% | 7.9M +104.46% | -177.3M +296.41% | |
Capital Expenditures | 32.9M +12.54% | 29.2M +40.62% | 20.8M -38.94% | 34.1M -12.37% | |
Cash from Investing Activities | -46.7M -136.40% | 128.3M +145.02% | -285.1M +1,224.07% | -21.5M -146.70% | |
Dividends Paid | 1.5M N/A | 0 N/A | 0 -100.00% | 7.5M N/A | |
Cash from Financing Activities | 133.5M +277.57% | -75.2M -207.17% | 70.2M -45.27% | 128.2M +3.13% | |
Financials Ratio | |||||
Gross Margin | 29.29% +3.46% | 28.31% +20.81% | 23.43% +26.05% | 18.59% -22.57% | |
Operating Margin | -277.93% +1,154.83% | -22.15% -89.86% | -218.41% +124.84% | -97.14% +277.10% | |
Return on Assets | -69.46% +1,109.19% | -5.74% -80.71% | -29.78% +258.32% | -8.31% -21.16% | |
Return on Equity | -88.27% +1,117.67% | -7.25% -80.75% | -37.66% +249.82% | -10.77% -29.20% | |
Revenue Growth | 4.10% -84.10% | 25.80% +13,092.55% | -0.20% -100.88% | 22.47% -100.00% | |
Current Ratio | 2.46 +8.45% | 2.27 +26.88% | 1.79 -37.71% | 2.87 +30.15% | |
Cash Ratio | 0.79 +3.62% | 0.76 +59.93% | 0.48 -67.83% | 1.48 +21.87% | |
Debt-to-Equity Ratio | 0.17 +81.71% | 0.09 -46.54% | 0.17 +277.75% | 0.05 -2.94% | |
Debt-to-Assets Ratio | 0.12 +62.47% | 0.08 -43.39% | 0.13 +259.89% | 0.04 +5.95% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow